Monospecific anti-topramezone monoclonal antibody and application thereof
By preparing a monoclonal antibody specifically against benzoxazine and establishing an enzyme-linked immunosorbent assay (ELISA) method, the problems of high cost and complex operation in the existing technology for benzoxazine detection have been solved, and rapid, high-volume, and low-cost detection with high specificity and high sensitivity has been achieved.
Patent Information
- Application Number
- CN202411103278.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-12
- Publication Date
- 2024-11-05
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Existing methods for detecting benzoxazine residues require expensive instruments and complex procedures, making it difficult to achieve rapid, high-volume, and low-cost detection.
The study aimed to prepare a monoclonal antibody specifically targeting benzoxazine, and to establish an enzyme-linked immunosorbent assay (ELISA) method by synthesizing immunogens and coating agents. This included preparing highly specific monoclonal antibodies and developing corresponding ELISA kits.
It enables rapid, high-volume, and low-cost detection of benzoxazine, exhibiting high specificity and sensitivity, with an IC50 value of 0.604 μg/L and a detection limit of 0.153 μg/kg.
Smart Images

Figure CN118894940A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of immunoassay, and in particular to a monospecific anti-mefenacet monoclonal antibody and application thereof. Background Art
[0002] Topramezone is a benzoyl pyrazolone herbicide developed by BASF. It is a new type of 4-hydroxyphenylpyruvate dioxygenase inhibitor. It can effectively control annual grass weeds and broadleaf weeds in corn fields, and has the characteristics of high efficiency and high safety. The molecular formula of topramezone is C 16 H17N3O5S, with a relative molecular mass of 363.388. Benpyrazone was registered in the United States in early 2005 and first registered in Canada in 2006 for post-emergence weed control in corn fields. Since then, it has been registered and marketed in many countries and regions around the world. As a herbicide, the mechanism of action of benpyrazone is to inhibit the enzyme 4-hydroxyphenylpyruvate dioxygenase (4-HPPD) in the target plant, resulting in chlorophyll loss and necrosis in the growing bud tissue, thereby causing the weeds to bleach and die. The residues of benpyrazone in the soil are persistent, with a half-life of more than 125 days. Improper use may lead to continuous pollution in the environment and transfer to animals through crop straw and grains, which may eventually endanger human health. Benpyrazone inhibits the 4-HPPD enzyme in the mammalian system, which may lead to increased levels of L-lysine in the serum and increased levels of tyrosine, which may cause chronic keratitis in animals. In addition, its acidic metabolite M670H05 may cause symptoms of cell proliferation and carcinogenesis of cell adenomas. To ensure food safety, different countries and organizations have established maximum residue limits (MRLs) for fenpyrotone in corn, pigs, cattle and poultry, ranging from 0.01 to 0.8 mg / kg.
[0003] The residual detection methods of fenpyroxetine include high performance liquid chromatography (HPLC), ultra high performance liquid chromatography (UPLC), liquid chromatography-mass spectrometry (LC-MS), etc. Although these methods have high sensitivity and accuracy, they require expensive instruments and complex operating procedures. Summary of the invention
[0004] The main purpose of the present invention is to propose a monoclonal antibody against fenpyroxene and its application, aiming to prepare a monoclonal antibody with strong specificity by synthesizing an immunogen and a coating agent, and to establish a corresponding enzyme-linked immunosorbent assay method to achieve rapid, large-scale and low-cost detection of fenpyroxene.
[0005] To achieve the above objectives, in a first aspect, the present invention provides a monospecific anti-mefenacet monoclonal antibody, wherein the monospecific anti-mefenacet monoclonal antibody hapten is prepared by reacting mefenacet with ethyl 4-bromobutyrate, and the structure is shown in Formula I:
[0006]
[0007] The immunogen is obtained by the reaction of the immune hapten and bovine serum albumin (BSA), and the coating agent is obtained by the reaction of the coating hapten and chicken ovalbumin (OVA).
[0008] The present invention adopts a hapten as an immune hapten, couples it with a carrier protein BSA to obtain an immunogen and uses it to immunize mice, couples it with a carrier protein OVA to obtain a coating, uses an ELISA method to perform serum detection, takes the spleen of mice with good immune effects and fuses it with tumor cells, screens to obtain hybridoma cell lines, and finally uses ascites to induce monoclonal antibodies.
[0009] In a second aspect, the present invention proposes the use of a monospecific anti-mefenacet monoclonal antibody in the preparation of a kit for detecting mefenacet.
[0010] In a third aspect, the present invention provides a kit, comprising the monospecific anti-mefenacet monoclonal antibody as described above.
[0011] Wherein, the kit is an enzyme-linked immunosorbent assay kit for monospecific detection of fenthion.
[0012] In a fourth aspect, the present invention provides an enzyme-linked immunosorbent assay for monospecifically detecting fenpyroxene residues in food, the method using the monospecific anti-fenpyroxene monoclonal antibody as described above, the method comprising the following steps:
[0013] Step S10, diluting the coating source and coating the solid phase carrier;
[0014] Step S20, diluting the monoclonal antibody to prepare a monoclonal antibody working solution;
[0015] Step S30, extracting the sample to be tested with an organic solvent and preparing a sample solution to be tested;
[0016] Step S40, adding the sample solution to be tested and the monoclonal antibody working solution to the solid phase carrier and incubating;
[0017] Step S50, adding goat anti-mouse IgG (enzyme-labeled secondary antibody) labeled with horseradish peroxidase and incubating;
[0018] Step S60, adding substrate solution and stop solution for color development, measuring OD value with a microplate reader and calculating the content of fenpyrotone.
[0019] The concentration of the coating source after dilution is 2 μg / mL, the concentration of the monoclonal antibody working solution is 1 μg / mL, and the color development times of the monoclonal antibody, enzyme-labeled secondary antibody and substrate solution are 40 min, 35 min and 15 min, respectively.
[0020] The beneficial effects of the present invention are:
[0021] 1. Specificity: The monospecific anti-mefenacet monoclonal antibody of the present invention can achieve monospecific detection of mefenacet, and has no cross-reaction with other HPPD-type herbicides of the same type (including pyrasulfotole, isoxathiapiprolin, pyrazolamide, tampoxadone, sulfotrione, and mesotrione).
[0022] 2. Sensitivity: The monospecific anti-benzazone monoclonal antibody of the present invention has a high recognition sensitivity to benzathine. By optimizing the detection conditions, the detection sensitivity is further improved, and finally IC 50 The value reached 0.604μg / L, and the minimum detection limit in corn, pork, beef and mutton reached 0.153μg / kg. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on the structures shown in these drawings without paying creative work.
[0024] Figure 1 It is the standard curve of the enzyme-linked immunosorbent assay for detecting fenpyroxetine in Example 3 of the present invention, wherein the X-axis is the concentration of the fenpyroxetine standard solution, and the Y-axis is the absorbance value of the standard solution divided by the absorbance value of the blank well (B / B0).
[0025] The realization of the purpose, functional features and advantages of the present invention will be further explained in conjunction with embodiments and with reference to the accompanying drawings. DETAILED DESCRIPTION
[0026] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0027] At present, in the field of benzathine residue detection, the enzyme-linked immunosorbent assay based on immunoassay is the most mature and most recognized method. The method is simple to operate and cost-effective, and is very suitable for screening large quantities of samples. The present invention synthesizes immunogens and coatings to prepare monoclonal antibodies with strong specificity, and establishes a corresponding enzyme-linked immunosorbent assay method to achieve rapid, large-scale and low-cost detection of benzathine.
[0028] Example 1: Preparation of fenthion immunogen and coating:
[0029] 1. Preparation of hapten:
[0030] Weigh 40 mg of benzathiapiprolin hapten and 4.4 mg of NaOH into a reaction flask, add 12 mL of DMF, stir for 15 min, then add 64.48 mg of ethyl 4-bromobutyrate and 1.34 mg of DMAP, react at 60 ° C for 5-6 hours, detect the degree of reaction by TLC, add 8 mL of triple distilled water to quench the reaction, extract with ethyl acetate, take the upper layer of the solution and blow dry with nitrogen to obtain the intermediate product benzathiapiprolin ester, re-dissolve the benzathiapiprolin ester with 2 mL of triple distilled water, adjust the solution pH to 12 with 1 M LiOH, hydrolyze for 2-3 hours, extract with ethyl acetate, take the upper layer of the solution and blow dry with nitrogen to obtain the hapten.
[0031] 2. Preparation of immunogen:
[0032] Weigh 20 mg of hapten and dissolve it in 0.5 mL of DMF, add 9 mg of NHS and 20 mg of EDC, stir at room temperature overnight; centrifuge at 10,000 r / min for 5 min. Weigh 30 mg of BSA and dissolve it in 10 mL of PBS (pH = 7.4). Add the above activation solution drop by drop into the BSA solution, stirring while adding, and stir at 4°C for 5-6 hours. Put the above reaction solution into a dialysis bag, dialyze with PBS at 4°C for 3-5 days, change the dialysate three times a day, centrifuge at 10,000 r / min for 10 min, and store the supernatant in a -20°C refrigerator for later use.
[0033] 3. Preparation of coating source:
[0034] Weigh 20 mg of fenthion hapten and dissolve it in 0.5 mL DMF, add 9 mg of NHS and 20 mg of EDC, and stir overnight at room temperature. Weigh 20 mg of OVA and fully dissolve it in 7 mL of PBS (pH = 7.4). Add the above activation solution drop by drop into the OVA solution, stirring while adding, and stir for 5-6 hours at 4°C. Put the above reaction solution into a dialysis bag, dialyze with PBS at 4°C for 3-5 days, change the dialysis solution three times a day, centrifuge at 10000r / min for 10 minutes, and store the supernatant in a -20°C refrigerator for later use.
[0035] Example 2: Preparation of monoclonal antibody against fenthion:
[0036] 1. Animal immunization:
[0037] BALB / c mice were immunized with the benzathine immunogen prepared in Example 1, and the tail tip vein serum was collected on the 7th day after four immunizations to determine whether the prepared benzathine antigen had immune activity. Selected 5-6 week-old BALB / c mice were immunized, and the 1 mg / mL complete antigen prepared above was emulsified evenly with an equal amount of Freund's adjuvant, and then immunized by subcutaneous multi-point injection, 100 μL per mouse. Freund's complete adjuvant was used for the first immunization, and Freund's incomplete adjuvant was used for booster immunization. After mixing evenly with physiological saline during sprint immunization, it was directly injected intraperitoneally; the first and second immunizations were separated by 3 weeks, and the booster immunization interval was 2 weeks. After the third immunization, blood was collected at intervals of one week to detect serum titer and inhibition; the mice with the best inhibition were selected, and sprint immunization was performed 3 days after the impact immunization to prepare for fusion.
[0038] 2. Cell fusion:
[0039] Three days after the sprint immunization, cell fusion was performed according to the conventional PEG (molecular weight 2000) method. The specific steps are as follows:
[0040] a. Eyeballs of mice were removed for blood collection. After killing the mice by cervical dislocation, the mice were immediately placed in 75% alcohol for disinfection and soaked for about 5 minutes. The spleen of the mice was removed by aseptic operation, and the spleen was moderately ground with a homogenizer and passed through a 40 μm cell sieve to obtain a spleen cell suspension, which was collected and centrifuged (1200 rpm, 8 minutes). The spleen cells were washed three times with RPMI-1640 medium. After the last centrifugation, the spleen cells were diluted to a certain volume, counted, and set aside; SP2 / 0 cells were collected:
[0041] b. 7-10 days before fusion, culture SP2 / 0 tumor cells in RPMI-1640 medium containing 10% fetal bovine serum in a 5% CO2 incubator. Before fusion, the number of SP2 / 0 tumor cells should reach 1-4×10 7 , to ensure that SP2 / 0 tumor cells are in the logarithmic growth phase before fusion. When fusion occurs, tumor cells are collected, suspended in RPMI-1640 basal culture medium, and cell counts are performed.
[0042] c. Splenocytes and SP2 / 0 cells were mixed at a counting ratio of 1:10, and fused with 50% PEG after centrifugation for 1 min. Then, RPMI-1640 basal culture medium was added in a descending order, and after centrifugation, the cells were suspended in RPMI-1640 screening culture medium containing 20% fetal bovine serum and 2% 50×HAT, added to a 96-well cell culture plate, and cultured in an incubator at 37°C and 5% CO2.
[0043] 3. Cell screening:
[0044] On the third day of cell fusion, the fused cells were half-changed with RPMI-1640 screening medium, and on the fifth day, the medium was completely replaced with RPMI-1640 transition medium containing 20% fetal bovine serum and 1% 100×HT. On the seventh day, the cell supernatant was taken for screening. The screening was divided into two steps: the first step was to screen the positive cell wells with indirect ELISA, and the second step was to use benzathone as the standard and to measure the inhibitory effect of positive cells with indirect competitive ELISA. The cell wells that had good inhibition on the standard were selected, subcloned by limiting dilution method, and tested by the same method. Repeat three times to obtain a hybridoma cell line that produces benzathone monoclonal antibodies.
[0045] 4. Preparation of monoclonal antibodies:
[0046] 8-10 week old BALB / c mice were taken and each mouse was intraperitoneally injected with 1 mL of sterile paraffin oil. Seven days later, each mouse was intraperitoneally injected with 1×10 6 Hybridoma cells, ascites was collected from the seventh day, and the subtype of the monoclonal antibody obtained by the present invention was identified using a mouse monoclonal antibody subtype identification kit purchased from Wuhan Sanying Biotechnology Co., Ltd. The results showed that the heavy chain was IgG1 subtype and the light chain was Kappa subtype. The concentration of the antibody was 35.59 mg / mL as determined by a BCA protein concentration kit. The collected ascites was stored in a -20°C refrigerator.
[0047] Example 3: Development of ELISA rapid detection kit:
[0048] 1. Establishment and optimization of enzyme-linked immunosorbent assay:
[0049] 1.1. Preparation of reagents (the reagents used in this example were prepared using the following method unless otherwise specified);
[0050] Phosphate-buffered saline (PBS, pH 7.4): weigh 8.00 g NaCl, 0.20 g KH2PO4, 2.90 g Na2HPO4·12H2O, and 0.20 g KCl, dissolve in a small amount of deionized water, and make up to 1000 mL (Note: When the pH is not specified in the text, the PBS is pH 7.4);
[0051] Coating solution: weigh 1.59g Na2CO3, 2.93g NaHCO3, dissolve in a small amount of deionized water, and make up to 1000mL;
[0052] Washing solution: 8.0 g NaCl, 0.2 g KH2PO4, 2.9 g Na2HPO4·12H2O, 0.2 g KC1, 0.5 mL Tween20, add triple distilled water to 1000 mL, adjust pH to 7.4;
[0053] Blocking solution: weigh 10.00 g of ovalbumin and dissolve it in 1000 mL of phosphate buffer;
[0054] Substrate A solution: weigh 160 mg TMB, add 10 ml dimethylacetamide and dissolve and mix;
[0055] Substrate B solution: weigh 13.70 g citric acid, 10.14 g trisodium citrate and 282.00 mg urea hydrogen peroxide, dissolve in a small amount of deionized water, and make up to 1000 mL;
[0056] Substrate mixture: aspirate 10mL of substrate B solution, add 100μL of substrate A solution, mix well, and use immediately after preparation;
[0057] Stop solution: Measure 100 mL of concentrated sulfuric acid and slowly add it dropwise into 800 mL of deionized water.
[0058] 1.2. Determination of coating original concentration and antibody working concentration:
[0059] Determine the coating source concentration and antibody working concentration according to the square array titration method. Select the above-mentioned synthetic coating source for coating, dilute it with CBS to 7 concentrations of 0.0625, 0.125, 0.25, 0.5, 1, 2 and 4 μg / mL, then add each concentration to the ELISA plate vertically, 100 μL per well, coat overnight at 4°C, and wash 3 times. Add 250 μL of 1% OVA solution to the ELISA well, incubate at 37°C for 40 minutes, take out, and wash 3 times. Add 50 μL of PBS to the ELISA well, dilute the monoclonal antibody prepared in Example 2 with PBS to 10 concentrations of 0.25, 0.5, 1, 2, 4, 6, 8, 10, 12 and 14 μg / mL, add it horizontally to the ELISA plate, 50 μL per well, incubate at 37°C for 40 minutes, take out, and wash 3 times. HRP-labeled goat anti-mouse secondary antibody was diluted to a working concentration of 1:10000 (lot number PA174421, Thermo Fisher Scientific Inc.) with PBS, 100 μL per well, incubated at 37°C for 35 min, then removed and washed 3 times. 100 μL of color development solution was added to the enzyme-labeled wells, color developed at 37°C in the dark for 15 min, 50 μL of stop solution was added, and the optical density (OD value) was measured at a wavelength of 450 nm using an enzyme reader. The antigen coating concentration and antibody dilution combination corresponding to the wells with OD values close to 1.8 and significant differences from the OD values of adjacent wells was selected.
[0060] The experimental results are shown in Table 1. When the coating concentration was 2 μg / mL and the antibody working concentration was 1 μg / mL, the OD450 value of the blank well was 2.596, which was quite different from the adjacent values, and the next step of optimization was carried out.
[0061] Table 1 Titration of monoclonal antibody against fenthion
[0062]
[0063] 1.3. Establishment of standard curve:
[0064] The fenpyrazone standard solution was prepared into 10 series of standard concentrations of 0.03125, 0.0625, 0.125, 0.25, 0.5, 1, 2, 4, 8 and 16 μg / L, and the fenpyrazone standard curve was established according to the optimized ELISA method conditions. The four-parameter standard curve was drawn with the fenpyrazone solution concentration as the horizontal axis and B / B0 as the vertical axis, and the IC50 value was calculated. The results are shown in Figure 1 The regression equation of the standard curve is y=A+(BA) / [1+e^(-a*x+b)], where A=0.97634, B=0.09466, a=2.36726, b=-0.39579, R2=0.99903, and the IC50 value is 0.605 μg / L.
[0065] 1.4. Cross-reaction rate test:
[0066] Six drugs, including pyrasulfotole, isoxathiapiprolin, pyrazol, tampron, sulfotrione, and mesotrione, were prepared into appropriate concentrations. The standard curves of these drugs were established according to the optimized conditions and the IC 50 The IC50 value of the fenpyroxil standard was used as the standard to compare and calculate the cross-reaction rate of other compounds. The results are shown in Table 2. Among the existing herbicides with similar structures, the antibody can ensure monospecific recognition of fenpyroxil.
[0067] Table 2 Cross-reactivity rates of monoclonal antibody FQs
[0068] Herbicide name <![CDATA[IC 50 (μg / L)]]> CR(%) Mefenacet 0.0375 100 Sulfonylpyrazone >1000 <0.0604% Isotrione >1000 <0.0604% Pyrazol >1000 <0.0604% Tembotrione >1000 <0.0604% Sulcotrione >1000 <0.0604% Mesotrione >1000 <0.0604%
[0069] 2. Assembly of ELISA rapid test kit:
[0070] 2.1. The rapid detection kit of the present invention is composed of the following parts:
[0071] (1) a solid phase carrier (ELISA plate) coated with a fenthion coating agent;
[0072] (2) 7 bottles of fenpyroxil standard solution, with concentrations of 0.03125, 0.0625, 0.125, 0.25, 0.5, 1, 2, 4, 8, and 16 μg / L;
[0073] (3) Anti-mefenacet monoclonal antibody concentrate 35.59 mg / mL;
[0074] (4) Horseradish peroxidase (HRP) labeled goat anti-mouse IgG antibody working solution;
[0075] (5) Concentrated phosphate buffer: 80.0 g NaCl, 2.0 g KH2PO4, 29.0 g Na2HPO4·12H2O, 2.0 g KCl, add deionized water to 1000 mL;
[0076] (6) Concentrated washing solution: 80.0 g NaCl, 2.0 g KH2PO4, 29.0 g Na2HPO4·12H2O, 2.0 g KCl, add double distilled water to 1000 mL; 5 mL Tween 20, add deionized water to 1000 mL;
[0077] (7) Substrate A solution: Accurately weigh 160 mg of TMB, add 10 mL of dimethylacetamide and dissolve and mix;
[0078] (8) Substrate B solution: accurately weigh 13.70 g of citric acid, 10.14 g of trisodium citrate and 282.00 mg of urea hydrogen peroxide, dissolve in a small amount of deionized water, and make up to 1000 mL; Substrate mixed solution: accurately pipette 10 mL of substrate B solution, add 100 μL of substrate A solution, mix well, and use immediately after preparation;
[0079] (9) Stop solution: Accurately measure 100 mL of concentrated sulfuric acid and slowly add it dropwise into 800 mL of deionized water.
[0080] 2.2. Preparation of ELISA plate:
[0081] Dilute the coating original to 2.00μg / mL with the coating solution, add 100μL to each well, and incubate overnight at 4℃. Shake off the coating solution, add 250μL PBST washing solution to each well, wash 3 times, pat dry, then add 200μL 1% OVA blocking solution to each well, incubate at 37℃ for 1.5h, pour off the liquid in the well, wash 3 times, pat dry, and vacuum seal with tin foil for storage.
[0082] 3. Determination procedure of ELISA rapid test kit:
[0083] 3.1. Preparation of reagents:
[0084] (1) Sample extract: Take 50 mL of acetonitrile, add 50 mL of triple distilled water and mix well;
[0085] (2) Phosphate buffer: dilute the concentrated phosphate buffer provided in the kit 10 times with deionized water before use;
[0086] (3) Washing solution: Dilute the washing solution provided in the kit 10 times with triple distilled water before use;
[0087] (4) Monoclonal antibody working solution: Dilute the monoclonal antibody concentrate with phosphate buffer to a final concentration of 1.00 μg / mL.
[0088] 3.2. Sample pretreatment:
[0089] Corn, pork, beef and mutton: weigh 1g±0.01g sample into a 10mL centrifuge tube, add 5mL of extractant, shake for 3min, centrifuge at 4000r / min, 4℃ for 5min; take 2.5mL of supernatant, blow dry with nitrogen at 25℃; add 5mL of reconstituted working solution, vortex for 3min, filter the liquid through a 0.22μm filter membrane, and dilute 10 times before testing.
[0090] 3.3, Determination steps:
[0091] (1) Sample addition: Add 50 μL of the fenthion series concentration standard solution or sample extract to the microwells of the ELISA plate, then add 50 μL of the monoclonal antibody working solution, place in a wet box, and incubate at 37°C for 40 min;
[0092] (2) Washing: Pour out the liquid in the wells, add 250 μL of washing solution to each well, wash three times and pat dry;
[0093] (3) Add horseradish peroxidase (HRP)-labeled goat anti-mouse IgG antibody working solution: Add 100 μL of horseradish peroxidase (HRP)-labeled goat anti-mouse IgG antibody working solution to each well, place in a wet box, and incubate at 37°C for 35 min;
[0094] (4) Washing: Pour out the liquid in the wells, add 250 μL of washing solution to each well, wash three times and pat dry;
[0095] (5) Add substrate: Add 100 μL of substrate mixture to each well, place in a wet box, and incubate at 37°C for 15 min;
[0096] (6) Add stop solution: Add 50 μL of stop solution to each well;
[0097] (7) Determination: The optical density (OD value) of each well was measured at a wavelength of 450 nm using an ELISA reader.
[0098] 3.4. Result judgment:
[0099] Standard curve:
[0100] A standard curve was drawn with the measured OD value of the standard divided by the OD value of the blank well (B / B0) as the ordinate and the drug concentration as the abscissa, and a four-parameter regression was performed to obtain a regression equation.
[0101] Calculation of the concentration of fenpyroxetine in the sample:
[0102] The inhibition rate of the sample was calculated (the OD value of the sample obtained was divided by the OD value of the blank well), and the result was substituted into the regression equation of the standard curve to calculate the concentration of fenthion in the sample.
[0103] 4. Tests on sensitivity, precision, accuracy and repeatability of the test kit:
[0104] 4.1. Sensitivity test of the kit:
[0105] IC of the standard curve 50 The sensitivity index of the detection kit of the present invention is as follows: the minimum detection limit (LOD) of corn, pork, beef and mutton is used as the sensitivity index of the detection kit of the present invention. The fenpyroxil standard is diluted to 10 concentrations of 0.03125, 0.0625, 0.125, 0.25, 0.5, 1, 2, 4, 8 and 16 μg / L, 5 replicates are performed for each concentration, and the determination is repeated 5 times according to the enzyme-linked immunosorbent assay method, and the IC values of the 5 determinations are taken. 50 The LOD is determined by the following steps: measuring the OD values of 20 blank corn, pork, beef and mutton samples, calculating the corresponding benzathine concentrations according to the regression equation of the standard curve, and then calculating the average value (X) and standard deviation (SD) of the benzathine concentrations, calculating the minimum detection limit in corn, pork, beef and mutton according to the formula Z=X+3×SD, and calculating the limit of quantification (LOQ) in corn, pork, beef and mutton according to the formula Z=X+10×SD. The IC50 value of the present invention is 0.605 μg / L, and the minimum detection limit of benzathine in corn, pork, beef and mutton is shown in Table 3.
[0106] Table 3 Detection limits of fenpyroxetine in actual samples
[0107] sample LOD (μg / kg) LOQ (μg / kg) corn 0.215 0.714 pork 0.204 0.624 beef 0.153 0.371 mutton 0.273 0.904
[0108] 4.2. Precision test of the kit:
[0109] The fenpyroxil standard was diluted to 10 concentrations of 0.03125, 0.0625, 0.125, 0.25, 0.5, 1, 2, 4, 8 and 16 μg / L, with 5 replicate wells for each concentration. The assay was repeated 5 times using the enzyme-linked immunosorbent assay method. The regression equation of the standard curve was used to calculate the measured values of the standard solution at each concentration, and the intra-plate and inter-plate coefficients of variation were calculated. The results are shown in Table 4.
[0110] Table 4 Intra-plate and inter-plate coefficients of variation of standard curves
[0111]
[0112]
[0113] 4.3. Accuracy and repeatability test of the kit of the present invention:
[0114] Different drug concentrations were added to corn, pork, beef and mutton according to the residue limits, and the recovery and coefficient of variation were calculated according to Formula 1. The results are shown in Table 5. The average recovery of the four samples was 79.60%-104.52%, and the coefficient of variation was less than 11.68%.
[0115] Recovery rate (%) = measured concentration / added concentration × 100% (Formula 1)
[0116] Table 5 Recovery of benzathine in actual samples
[0117]
[0118] The beneficial effects of the present invention are:
[0119] 1. Specificity: The monospecific anti-mefenacet monoclonal antibody of the present invention can achieve monospecific detection of mefenacet, and has no cross-reaction with other HPPD-type herbicides of the same type (including pyrasulfotole, isoxathiapiprolin, pyrazolamide, tampoxadone, sulfotrione, and mesotrione).
[0120] 2. Sensitivity: The monospecific anti-benzazone monoclonal antibody of the present invention has a high recognition sensitivity to benzathine. By optimizing the detection conditions, the detection sensitivity is further improved, and finally IC 50 The value reached 0.604μg / L, and the minimum detection limit in corn, pork, beef and mutton reached 0.153μg / kg.
[0121] The above description is only a preferred embodiment of the present invention, and does not limit the patent scope of the present invention. All equivalent structural changes made by using the contents of the present invention specification and drawings under the inventive concept of the present invention, or directly / indirectly applied in other related technical fields are included in the patent protection scope of the present invention.
Claims
1. A monospecific anti-mefenacet monoclonal antibody, characterized in that: The monospecific anti-mefenacet monoclonal antibody hapten is prepared by reacting mefenacet with ethyl 4-bromobutyrate, and its structure is shown in Formula I: The immunogen is obtained by the reaction of the immune hapten and bovine serum albumin, and the coating agent is obtained by the reaction of the coating hapten and chicken ovalbumin.
2. Use of the monospecific anti-mefenacet monoclonal antibody according to claim 1 in the preparation of a kit for detecting mefenacet.
3. A kit, characterized in that: The kit comprises the monospecific anti-mefenacet monoclonal antibody according to claim 1.
4. The kit according to claim 3, characterized in that The kit is an enzyme-linked immunosorbent assay kit for monospecific detection of fenpyroxetine.
5. A monospecific enzyme-linked immunosorbent assay for detecting fenthion residues in food, characterized in that: The method uses the monospecific anti-mefenacet monoclonal antibody according to claim 1, and the method comprises the following steps: Step S10, diluting the coating source and coating the solid phase carrier; Step S20, diluting the monoclonal antibody to prepare a monoclonal antibody working solution; Step S30, extracting the sample to be tested with an organic solvent and preparing a sample solution to be tested; Step S40, adding the sample solution to be tested and the monoclonal antibody working solution to the solid phase carrier and incubating; Step S50, adding goat anti-mouse IgG labeled with horseradish peroxidase and incubating; Step S60, adding substrate solution and stop solution for color development, measuring OD value with a microplate reader and calculating the content of fenpyrotone.
6. The monospecific enzyme-linked immunosorbent assay for detecting fenpyroxil residues in food according to claim 5, characterized in that: The concentration of the coating source after dilution is 2 μg / mL, the concentration of the monoclonal antibody working solution is 1 μg / mL, and the color development times of the monoclonal antibody, goat anti-mouse IgG labeled with horseradish peroxidase and substrate solution are 40 minutes, 35 minutes and 15 minutes respectively.
Citation Information
Patent Citations
Hybridoma cell strain capable of secreting isoxaflutole monoclonal antibody and application of hybridoma cell strain
CN112574957A
Monoclonal antibody, preparation method, application, enzyme-linked immunosorbent assay and immunochromatography method
CN118388655A
Cited By
Hybridoma cell strain secreting monoclonal antibody of triketone herbicide and metabolite of triketone herbicide and application of hybridoma cell strain
CN120210131A
Compound containing 1-methyl-4-(p-toluoyl)-1H-pyrazol-5-yl carboxylic ester structure and application of compound as herbicide
CN121873057A
